Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000540889 | SCV000637035 | benign | Brugada syndrome | 2023-12-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001696944 | SCV000725274 | likely benign | not provided | 2020-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350243 | SCV002652720 | likely benign | Cardiovascular phenotype | 2019-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004586773 | SCV005076025 | benign | not specified | 2024-04-28 | criteria provided, single submitter | clinical testing |